

VCBeat Health Contact Us

China Healthcare Select

Vertical Industries 

Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory

Home Sinopep Allsino's Semaglutide API Receives Brazil CADIFA Approval

Sinopep Allsino's Semaglutide API Receives Brazil CADIFA Approval

May 29, 2026 16:11 CST Updated 17:17

Share:

Sinopep

Developer, Manufacturer, and Distributor of Peptides and Small-Molecule Chemical Drugs

vcbeatglobal@vcbeat.net 

SERVICES

Partnership Development Market Entry Advisory Ecosystem Engagement Advisory

COMPANY

About VCBeat Why VCBeat Contact Us

CHANNELS

China Healthcare Select Insights MNC China Lens Events VB100 GMPC

MORE

PRIVACY VCBEAT CHINA

© 2025 VCBeat. All rights reserved.